IPP Bureau

Mandaviya convenes meeting to reiterate the nation’s commitment to addressing gender inequality
Mandaviya convenes meeting to reiterate the nation’s commitment to addressing gender inequality

By IPP Bureau - October 21, 2023

Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20

Global Hand Washing Day: Sir HN Reliance Foundation Hospital initiates awareness campaign for underprivileged students in Mumbai
Global Hand Washing Day: Sir HN Reliance Foundation Hospital initiates awareness campaign for underprivileged students in Mumbai

By IPP Bureau - October 20, 2023

hey were educated about the 7- step hand-washing technique trainings

Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules

By IPP Bureau - October 20, 2023

Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)

Need to include ASMD as a notified condition in the National Policy for rare diseases
Need to include ASMD as a notified condition in the National Policy for rare diseases

By IPP Bureau - October 20, 2023

ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another

Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs
Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs

By IPP Bureau - October 20, 2023

Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months

USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis

By IPP Bureau - October 20, 2023

Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials

Bajaj Healthcare completes construction of Alkaloid extraction plant at Vadodara
Bajaj Healthcare completes construction of Alkaloid extraction plant at Vadodara

By IPP Bureau - October 19, 2023

The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year

75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary

By IPP Bureau - October 19, 2023

Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”

GenWorks Health & Rotary Club partners to transform rural healthcare
GenWorks Health & Rotary Club partners to transform rural healthcare

By IPP Bureau - October 19, 2023

GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities

Clariant launches new range of excipients to improve stability and solubility of APIs at CPHI Barcelona
Clariant launches new range of excipients to improve stability and solubility of APIs at CPHI Barcelona

By IPP Bureau - October 19, 2023

New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral

Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials

By IPP Bureau - October 19, 2023

Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology

Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr

By IPP Bureau - October 18, 2023

Profit after tax (before exceptional items) up 23% to Rs 215 crores

Glenmark to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 diabetes
Glenmark to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 diabetes

By IPP Bureau - October 18, 2023

Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually

USFDA inspection at Biocon Biologics' manufacturing facility in Johor, Malaysia
USFDA inspection at Biocon Biologics' manufacturing facility in Johor, Malaysia

By IPP Bureau - October 18, 2023

Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection
Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection

By IPP Bureau - October 18, 2023

This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years

Latest Stories

Interviews

Packaging